| Document Date: 2005-07-06 02:13:57
Open Document File Size: 57,47 KBShare Result on Facebook
Company Sanofi-Synthelabo / Pharmaceutical Press / / Continent Europe / / Country France / Australia / United Kingdom / / / Facility Pharmacy Department / Patient stable Dose / / IndustryTerm treatment of negative symptoms / dosage algorithm / / MedicalCondition insomnia / myoclonus / hyperreflexia / prolactin-dependant tumours / schizophrenia / seizures / liver failure / dysfunction / migraine / rhabdomyolysis / torsade de pointes / Parkinson’s disease / bradycardia / neuroleptic malignant syndrome / infection / depression / hypokalemia / chronic schizophrenia / syndrome / hyperprolactinemia / hypotension / / Person Mark Allen / Kate Smith / / Position Governor / MP / / Product olanzapine / fluoxetine / sumatriptan / haloperidol / droperidol / Carbamazepine / risperidone / Fentanyl / lithium carbonate / / ProvinceOrState Iowa / / Technology Pharmacokinetics / dosage algorithm / / URL http /
SocialTag |
Profile of Amisulpride Graylands Hospital Drug Bulletin 2002 Vol 10 No 2 July ISSN[removed]Amisulpride (Solian) will become the latest addition to the range of atypical antipsychotics available in Australia,